This observation suggests a potential role of the PT in urinary nephrin and urinary vascular endothelial growth factor processing in early diabetic nephropathy, a fact which could be related to advanced glycation end-products intervention [13]. This evidence concerns the gene NPHS1 and diabetic kidney disease.